Some GLP-1s Achieve More Weight Loss Than Others
Less than 50% of employers cover GLP-1 drugs for weight loss: JPM survey
"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated that almost 50 million adults in employer plans meet the clinical criteria for taking such drugs, which can cost thousands of dollars annually per person," according to a report from Kaiser Family Health (KFF) in October.
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...
Jonathan Van Ness is getting candid about his weight loss journey. In a vulnerable new video posted to TikTok this week, the ...
While GLP-1 medications like Ozempic and Wegovy have garnered significant attention, bariatric surgery continues to ...
Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...
Most weight loss drugs were meant to be administered as treatment for those with Type 2 Diabetes Mellitus (T2DM), and weight ...
Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback